Home / Resource Library / Early identification of high-risk myelosuppression subtypes in DLBCL patients undergoing R-CHOP chemotherapy

Early identification of high-risk myelosuppression subtypes in DLBCL patients undergoing R-CHOP chemotherapy

Study investigated risk of myelosuppression in patients with DLBCL receiving R-CHOP therapy.